Philadelphia chromosome as a recurrent event among therapy-related acute leukemia

Am J Hematol. 2017 Feb;92(2):E18-E19. doi: 10.1002/ajh.24604.

Authors

Ibrahim Aldoss¹, Tracey Stiller², Joo Song³, Monzr Al Malki¹, Haris Ali¹, Amandeep Salhotra¹, Ahmed Aribi¹, Samer Khaled¹, Popsie Gaytan³, Joyce Murata-Collins³, Joycelynne Palmer², David Snyder¹, Margaret O'Donnell¹, Ryotaro Nakamura¹, Anthony S Stein¹, Stephen J Forman¹, Guido Marcucci¹, Vinod Pullarkat¹

Affiliations

¹ Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California.
² Division of Biostatistics, Department of Information Sciences, City of Hope, Duarte, California.
³ Department of Pathology, City of Hope, Duarte, California.

PMID: 27862221
DOI: 10.1002/ajh.24604

No abstract available

Publication types

Letter

MeSH terms

Combined Modality Therapy
Humans
Neoplasms, Second Primary / diagnosis*
Neoplasms, Second Primary / etiology*
Neoplasms, Second Primary / mortality
Neoplasms, Second Primary / therapy
Philadelphia Chromosome*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
Prognosis
Recurrence